-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
The net result for the period of deducting operating expenses from operating revenues.
-
Summary
-
bluebird bio, Inc. quarterly/annual Operating Income (Loss) history and growth rate from 2011 to 2023.
- bluebird bio, Inc. Operating Income (Loss) for the quarter ending March 31, 2024 was -$78.7M, a 832% decline year-over-year.
- bluebird bio, Inc. Operating Income (Loss) for the twelve months ending March 31, 2024 was -$334M, a 180% decline year-over-year.
- bluebird bio, Inc. annual Operating Income (Loss) for 2023 was -$244M, a 2.37% increase from 2022.
- bluebird bio, Inc. annual Operating Income (Loss) for 2022 was -$250M, a 57.7% increase from 2021.
- bluebird bio, Inc. annual Operating Income (Loss) for 2021 was -$591M, a 5.66% decline from 2020.
Operating Income (Loss), Trailing 12 Months (USD)
Operating Income (Loss), Annual (USD)
Operating Income (Loss), YoY Annual Growth (%)